PALLADINO; Michael A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for PALLADINO; Michael A..The latest application filed is for "compositions and methods for treating neoplastic diseases".

Company Profile

1.13.9

PALLADINO; Michael A. - Olivenhain CA
Palladino; Michael A. - Encinitas CA
Palladino; Michael A. - San Mateo CA
Palladino; Michael A. - Foster City CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Treating Neoplastic Diseases App 20200206190 - ANDERSON; Kenneth C. ; et al.	2020-07-02
Compositions and methods for treating neoplastic diseases Grant 10,610,517 - Anderson , et al.	2020-04-07
Compositions And Methods For Treating Neoplastic Diseases App 20140349965 - Anderson; Kenneth C. ; et al.	2014-11-27
Compositions and methods for treating neoplastic diseases Grant 8,722,724 - Anderson , et al. May 13, 2	2014-05-13
Interleukin-1 And Tumor Necrosis Factor-alpha Modulators; Syntheses Of Such Modulators And Methods Of Using Such Modulators App 20120238634 - Palladino; Michael A. ; et al.	2012-09-20
Interleukin-1 and tumor necrosis factor-.alpha. modulators; syntheses of such modulators and methods of using such modulators Grant 8,133,915 - Palladino , et al. March 13, 2	2012-03-13
Analogs of dehydrophenylahistins and their therapeutic use Grant 8,129,527 - Palladino , et al. March 6, 2	2012-03-06
Interleukin-1 And Tumor Necrosis Factor-alpha Modulators; Syntheses Of Such Modulators And Methods Of Using Such Modulators App 20110160309 - Palladino; Michael A. ; et al.	2011-06-30
Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof Grant 7,935,704 - Palladino , et al. May 3, 2	2011-05-03
Interleukin-1 and tumor necrosis factor-.alpha.modulators; syntheses of such modulators and methods of using such modulators Grant 7,893,299 - Palladino , et al. February 22, 2	2011-02-22
Methods Of Using [3.2.0] Heterocyclic Compounds And Analogs Thereof In Treating Waldenstrom's Macroglobulinemia App 20090156469 - Ghobrial; Irene ; et al.	2009-06-18
Methods Of Sensitizing Cancer To Therapy-induced Cytotoxicity App 20090148445 - Bonavida; Benjamin ; et al.	2009-06-11
Analogs Of Dehydrophenylahistins And Their Theapeutic Use App 20080221122 - Palladino; Michael A. ; et al.	2008-09-11
Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators App 20080064753 - Palladino; Michael A. ; et al.	2008-03-13
Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof App 20050197344 - Palladino, Michael A. ; et al.	2005-09-08
Tumor necrosis factor antagonists and their use Grant 5,795,967 - Aggarwal , et al. August 18, 1	1998-08-18
Fivemer cyclic peptide inhibitors of diseases involving .alpha..sub.v .beta..sub.3 Grant 5,780,426 - Palladino , et al. July 14, 1	1998-07-14
Tumor necrosis factor antagonists and their use Grant 5,672,347 - Aggarwal , et al. September 30, 1	1997-09-30
Method for the treatment of grafts prior to transplantation using TGF-.beta . Grant 5,135,915 - Czarniecki , et al. August 4, 1	1992-08-04
Method and compositions for the treatment and prevention of septic shock Grant 5,055,447 - Palladino , et al. October 8, 1	1991-10-08
Chemotactic assay for immunogenicity Grant 4,714,674 - Palladino December 22, 1	1987-12-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.